Advisor Group Holdings, Inc. Eiger Bio Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.21 - $0.43 $3,076 - $6,299	-14,650 Reduced 65.4%	7,750 $1,000
Q3 2023 Nov 13, 2023	SELL	$0.28 - $0.93 $1,260 - $4,185	-4,500 Reduced 16.73%	22,400 $6,000
Q2 2023 Aug 10, 2023	SELL	$0.55 - $1.26 $34,072 - $78,057	-61,950 Reduced 69.72%	26,900 $18,000
Q1 2023 May 12, 2023	SELL	$0.89 - $2.52 $49,306 - $139,608	-55,400 Reduced 38.41%	88,850 $79,000
Q4 2022 Feb 10, 2023	SELL	$1.02 - $7.48 $42,636 - $312,664	-41,800 Reduced 22.47%	144,250 $170,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $9.66 $257,304 - $411,516	42,600 Added 29.7%	186,050 $1.4 Million
Q2 2022 Aug 10, 2022	BUY	$4.99 - $8.96 $147,704 - $265,216	29,600 Added 26.0%	143,450 $904,000
Q1 2022 May 04, 2022	BUY	$3.84 - $9.74 $54,144 - $137,334	14,100 Added 14.14%	113,850 $944,000
Q3 2021 Nov 05, 2021	BUY	$6.68 - $9.1 $66,800 - $91,000	10,000 Added 11.14%	99,750 $667,000
Q2 2021 Aug 02, 2021	BUY	$7.82 - $9.23 $112,217 - $132,450	14,350 Added 19.03%	89,750 $764,000
Q1 2021 May 13, 2021	BUY	$8.44 - $12.66 $164,580 - $246,870	19,500 Added 34.88%	75,400 $668,000
Q4 2020 Feb 10, 2021	BUY	$7.98 - $12.29 $37,506 - $57,762	4,700 Added 9.18%	55,900 $687,000
Q3 2020 Nov 12, 2020	BUY	$7.96 - $12.42 $404,368 - $630,936	50,800 Added 12700.0%	51,200 $417,000
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $2,160 - $5,348	400 New	400 $4,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.